引用次数
引用: 97,128
H-指数: 136
I10-指数 : 357
出版物: 680
Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Nasser Hanna , David Johnson , Sarah Temin , Sherman Baker
Journal of Clinical Oncology 35 ( 30) 3484 -3515
2017
Molecular Determinants of Response to Anti-Programmed Cell Death (PD)-1 and Anti-Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non-Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing.
Hira Rizvi , Francisco Sanchez-Vega , Konnor La , Walid Chatila
Journal of Clinical Oncology 36 ( 7) 633 -641
1,028
2018
Next generation sequencing (NGS) in resectable non-small cell lung cancer (NSCLC): Therapeutic implications.
Valerie W. Rusch , Kay See Tan , Amanda Ghanie , Maria E. Arcila
Journal of Clinical Oncology 34 8541 -8541
2016
Association of outcomes and co-occuring genomic alterations in patients with KRAS-mutant non-small cell lung cancer.
Gregory J. Riely , Emmet Jordan , Hyunjae Ryan Kim , Helena Alexandra Yu
Journal of Clinical Oncology 34 9019 -9019
7
2016
Updated results of a phase 1 study of EGF816, a third-generation, mutant-selective EGFR tyrosine kinase inhibitor (TKI), in advanced non-small cell lung cancer (NSCLC) harboring T790M.
Daniel Shao-Weng Tan , James Chih-Hsin Yang , Natasha B. Leighl , Gregory J. Riely
Journal of Clinical Oncology 34 9044 -9044
34
2016
Concurrent genetic alterations identified by next-generation sequencing in pre-treatment, metastatic EGFR-mutant lung cancers.
Helena Alexandra Yu , Emmet Jordan , AI Ni , Daniel Feldman
Journal of Clinical Oncology 34 ( 15_suppl) 9053 -9053
8
2016
MDM2 amplification (Amp) to mediate cabozantinib resistance in patients (Pts) with advanced RET-rearranged lung cancers.
Romel Somwar , Roger Smith , Takuo Hayashi , Kota Ishizawa
Journal of Clinical Oncology 34 ( 15_suppl) 9068 -9068
20
2016
Next generation sequencing (NGS) in lung adenocarcinoma (LA) as a guide to treatment selection.
Emmet Jordan , David Barron , Nikolaus Schultz , Debyani Chakravarty
Journal of Clinical Oncology 34 ( 15_suppl) 9084 -9084
2016
Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer
David Jackman , William Pao , Gregory J. Riely , Jeffrey A. Engelman
Journal of Clinical Oncology 28 ( 2) 357 -360
892
2010
Response to osimertinib following treatment with EGF816 in patients with T790M EGFR mutant NSLCLC.
Kathryn Cecilia Arbour , Lecia V. Sequist , Zofia Piotrowska , Mark G. Kris
Journal of Clinical Oncology 35
6
2017
Twice weekly pulse and daily continuous-dose erlotinib as initial treatment for patients with epidermal growth factor receptor-mutant lung cancers and brain metastases.
Kathryn C. Arbour , Mark G. Kris , Gregory J. Riely , Ai Ni
Cancer 124 ( 1) 105 -109
11
2018
Improving therapy for patients with epidermal growth factor receptor-mutant lung cancer.
Kathryn C. Arbour , Gregory J. Riely
Cancer 124 ( 11) 2272 -2275
2018
Frequency and outcomes of brain metastases in patients with HER2‐mutant lung cancers
Michael Offin , Daniel Feldman , Ai Ni , Mackenzie L. Myers
Cancer 125 ( 24) 4380 -4387
15
2019
Differences in the survival of patients with recurrent versus de novo metastatic KRAS‐mutant and EGFR‐mutant lung adenocarcinomas
Helena A. Yu , Camelia S. Sima , Matthew D. Hellmann , Jarushka Naidoo
Cancer 121 ( 12) 2078 -2082
11
2015
Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib.
Jarushka Naidoo , Camelia S. Sima , Katherine Rodriguez , Natalie Busby
Cancer 121 ( 18) 3212 -3220
171
2015
Molecular on/off switch.
Daniel T. Milton , Gregory J. Riely , William Pao , Vincent A. Miller
Journal of Clinical Oncology 24 ( 30) 4940 -4942
11
2006
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.
William F. Novotny , James M. Isbell , Valerie W. Rusch , George Plitas
Nature Medicine 25 ( 12) 1928 -1937
161
2019
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
Alexander Drilon , Jeffrey W. Clark , Jared Weiss , Sai-Hong Ignatius Ou
Nature Medicine 26 ( 1) 47 -51
76
2020
Evaluating Variability in Tumor Measurements from Same-day Repeat CT Scans of Patients with Non–Small Cell Lung Cancer
Binsheng Zhao , Leonard P. James , Chaya S. Moskowitz , Pingzhen Guo
Radiology 252 ( 1) 263 -272
332
2009
Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis
Noriko Motoi , Janos Szoke , Gregory J. Riely , Venkatraman E. Seshan
The American Journal of Surgical Pathology 32 ( 6) 810 -827
314
2008